A technician works at Biocon Ltd.’s cancer drug facility in Bangalore (Photographer: Namas Bhojani/Bloomberg) 

Biocon’s Malaysian Plant Gets Six Observations From U.S. Drug Regulator

Biocon Ltd. said the U.S. drug regulator has issued form 483 for its Malaysia plant with six observations.“As per the normal expectations of the agency, we intend to respond with a corrective and p...

Bloomberg Quint

Add BloombergQuint App to Home screen.